Welcome to our dedicated page for Forian news (Ticker: FORA), a resource for investors and traders seeking the latest updates and insights on Forian stock.
Forian Inc (Nasdaq: FORA) delivers SaaS-powered data solutions for healthcare, life sciences, and emerging markets. This news hub provides investors and professionals with essential updates on operational developments, financial performance, and strategic initiatives.
Access curated press releases covering earnings disclosures, regulatory compliance updates, technology partnerships, and market expansion activities. Our repository enables efficient tracking of Forian's progress in data management innovation and clinical analytics leadership.
Key updates include product launch announcements, executive appointments, financial filings, and industry collaborations. Bookmark this page for centralized access to verified corporate communications that inform investment decisions and sector analysis.
Forian (Nasdaq: FORA) has announced a strategic partnership with Databricks to offer its Chartis™ product through the Databricks Marketplace. Chartis™, which utilizes Forian's proprietary scoring algorithm to map physician and organization affiliations, will be accessible via Delta Sharing, Databricks' open-source data-sharing protocol.
The partnership aims to expand access to healthcare analytics, enabling organizations to leverage real-world evidence for improved decision-making in healthcare research, drug development, and patient care. Chartis™ employs an event-based approach that evaluates proximity, recency, and share of services to provide detailed insights into provider connections across the healthcare ecosystem.
Forian Inc. (FORA) reported Q3 2024 financial results showing revenue of $4.7 million, a 12% decrease from $5.3 million in the prior year. The company recorded a net loss of $0.2 million ($0.01 per share), compared to net income of $4.3 million ($0.13 per share) in Q3 2023. Adjusted EBITDA decreased to $0.2 million from $1.1 million year-over-year. Cash and equivalents stood at $49.4 million. Notable events include the acquisition of Kyber Data Science and the redemption of 3.5% Convertible Notes worth over $15 million.
Forian Inc. (Nasdaq: FORA) has announced its participation in the 13th Annual ROTH MKM Technology Event, scheduled for November 19th-20th, 2024, at the Hard Rock Hotel in New York City. CEO and Executive Chairman Max Wygod and CFO Mike Vesey will represent the company at this exclusive event, which will feature over 70 growth companies from the technology sector.
The event format consists of 40-minute one-on-one and small group meetings between company executives and investors, providing opportunities for detailed discussions and comprehensive insights into participating companies.
Forian (Nasdaq: FORA), a provider of data science driven information and analytics solutions to healthcare and life sciences industries, has scheduled its third quarter 2024 financial results announcement for November 13, 2024, after market close. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. A replay of the call will be available on the company's investor website following the conclusion.
Forian Inc. (Nasdaq: FORA) has acquired Kyber Data Science from TD Cowen, strengthening its position in healthcare information analytics. Kyber specializes in advanced healthcare data analytics and machine learning solutions for the financial services industry. The acquisition expands Forian's market reach into financial services and adds Kyber's proprietary algorithms and software designed for hedge funds, private equity, and mutual fund customers. The merger combines Forian's data resources with Kyber's analytics capabilities to enhance services for both healthcare and financial industry clients.
Forian Inc. (Nasdaq: FORA) reported its Q2 2024 financial results, showing a slight decline in revenue and increased losses. Key points include:
- Revenue decreased 2% to $4.8 million
- Net loss from continuing operations increased to $2.6 million ($0.08 per share)
- Adjusted EBITDA decreased 81% to $0.08 million
- Cash, cash equivalents, and marketable securities totaled $48.0 million
The company expanded its Chronos™ data lake to offset potential data loss from a supplier. Forian updated its 2024 outlook, projecting revenue between $19-20 million and Adjusted EBITDA ranging from -$0.5 million to $0.5 million. Despite industry challenges, Forian remains focused on product differentiation and cost containment.
Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions for healthcare and life sciences industries, has announced it will release its second quarter 2024 financial results on Wednesday, August 14, 2024, after market close. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results.
Interested parties can register for the conference call online, and the webcast will be available live at a specified link. The earnings release and a replay of the call will be accessible on Forian's investor relations website promptly after the call concludes.
